InsidersTradesSigma
Follow the NextCell Pharma AB stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, NextCell Pharma AB has logged 0 insider filings. Market capitalisation: €109.7m. The full history is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
No declarations found
0 of 0 declarations
NextCell Pharma AB is a Swedish biopharmaceutical company focused on developing cell therapies for the treatment of type 1 diabetes. It is listed on the Stockholm Stock Exchange (XSTO).